Literature DB >> 14580958

Antimalarial chemotherapy: young guns or back to the future?

Giancarlo A Biagini1, Paul M O'Neill, Alexis Nzila, Stephen A Ward, Patrick G Bray.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 14580958     DOI： 10.1016/j.pt.2003.09.011

Source DB:  PubMed          Journal:  Trends Parasitol        ISSN： 1471-4922


× No keyword cloud information.
  14 in total

1.  Serotonin1A receptor agonist acquires an antimalarial connection.

Authors:  Amitabha Chattopadhyay; Shanti Kalipatnapu
Journal:  J Biosci       Date:  2004-03       Impact factor: 1.826

2.  Functional characterization and target validation of alternative complex I of Plasmodium falciparum mitochondria.

Authors:  Giancarlo A Biagini; Parnpen Viriyavejakul; Paul M O'neill; Patrick G Bray; Stephen A Ward
Journal:  Antimicrob Agents Chemother       Date:  2006-05       Impact factor: 5.191

Review 3.  Drug-resistant malaria.

Authors:  John E Hyde
Journal:  Trends Parasitol       Date:  2005-09-02

4.  Piperaquine and Lumefantrine resistance in Plasmodium berghei ANKA associated with increased expression of Ca2+/H+ antiporter and glutathione associated enzymes.

Authors:  Daniel Kiboi; Beatrice Irungu; Jennifer Orwa; Luna Kamau; Lynette Isabella Ochola-Oyier; Joseph Ngángá; Alexis Nzila
Journal:  Exp Parasitol       Date:  2014-10-18       Impact factor: 2.011

5.  Prodrugs of bisthiazolium salts are orally potent antimalarials.

Authors:  Henri J Vial; Sharon Wein; Christine Farenc; Clemens Kocken; Olivier Nicolas; Marie Laure Ancelin; Francoise Bressolle; Alan Thomas; Michèle Calas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-18       Impact factor: 11.205

6.  Kinetic, inhibition and structural studies on 3-oxoacyl-ACP reductase from Plasmodium falciparum, a key enzyme in fatty acid biosynthesis.

Authors:  Sasala R Wickramasinghe; Kirstine A Inglis; Jonathan E Urch; Sylke Müller; Daan M F van Aalten; Alan H Fairlamb
Journal:  Biochem J       Date:  2006-01-15       Impact factor: 3.857

7.  Genome wide adaptations of Plasmodium falciparum in response to lumefantrine selective drug pressure.

Authors:  Leah Mwai; Abdi Diriye; Victor Masseno; Steven Muriithi; Theresa Feltwell; Jennifer Musyoki; Jacob Lemieux; Avi Feller; Gunnar R Mair; Kevin Marsh; Chris Newbold; Alexis Nzila; Céline K Carret
Journal:  PLoS One       Date:  2012-02-27       Impact factor: 3.240

8.  Catestatin, an endogenous chromogranin A-derived peptide, inhibits in vitro growth of Plasmodium falciparum.

Authors:  Aziza Akaddar; Cécile Doderer-Lang; Melissa R Marzahn; François Delalande; Marc Mousli; Karen Helle; Alain Van Dorsselaer; Dominique Aunis; Ben M Dunn; Marie-Hélène Metz-Boutigue; Ermanno Candolfi
Journal:  Cell Mol Life Sci       Date:  2009-12-31       Impact factor: 9.261

9.  In Vitro Anti-plasmodial activity of Trigonella foenum-graecum L.

Authors:  M Palaniswamy; B V Pradeep; R Sathya; J Angayarkanni
Journal:  Evid Based Complement Alternat Med       Date:  2008-05-02       Impact factor: 2.629

10.  Continued cytoadherence of Plasmodium falciparum infected red blood cells after antimalarial treatment.

Authors:  Katie R Hughes; Giancarlo A Biagini; Alister G Craig
Journal:  Mol Biochem Parasitol       Date:  2009-10-01       Impact factor: 1.759
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.